Composition
- Active ingredients
- DAPTOMYCIN 500MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DAPTOMYCIN 500MG/VIAL · PowderANDA206005-001 · Prescription
- DAPTOMYCIN 350MG/VIAL · PowderNDA209949-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA091039-001 · Prescription
- DAPTOMYCIN 350MG/VIAL · PowderNDA203797-001 · Tentative approval
- DAPTOMYCIN 500MG/VIAL · PowderANDA207104-001 · Prescription
- DAPTOMYCIN 350MG/VIAL · PowderANDA213396-001 · Discontinued
- DAPTOMYCIN 350MG/VIAL · PowderANDA213425-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA213966-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA215215-001 · Discontinued
- DAPTOMYCIN 500MG/VIAL · PowderANDA217215-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA212513-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA216413-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · PowderANDA211961-001 · Prescription
- DAPTOMYCIN 500MG/VIAL · Powder
At a glance
- Brand name
- Daptomycin
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Hospira
- Status
- Discontinued
- FDA approval
- 12 Sept 2014
- Application
- ANDA202857-001